Home
Mail
TV
News
Sport
Finance
Lifestyle
Entertainment
Weather
Mobile
Yahoo
Mail
Cost Of Living
Watchlists
My Portfolios
Markets
Money
Work
Technology
Industries
Give Feedback
Australia markets closed
ALL ORDS
7,974.80
-27.70
(-0.35%)
ASX 200
7,724.30
-25.40
(-0.33%)
AUD/USD
0.6618
-0.0020
(-0.30%)
OIL
78.49
-0.13
(-0.17%)
GOLD
2,348.40
+30.40
(+1.31%)
Bitcoin AUD
99,932.68
+538.08
(+0.54%)
Inozyme Pharma, Inc. (INZY)
NasdaqGS - NasdaqGS Delayed price. Currency in USD
Add to watchlist
4.7400
-0.1100
(-2.27%)
At close: 04:00PM EDT
4.8500
+0.11
(+2.32%)
After hours:
06:32PM EDT
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
-
Operating expenses
Research development
62,101
54,847
47,849
37,720
46,493
-
Selling general and administrative
19,520
20,798
20,826
18,926
10,548
-
Total operating expenses
81,621
75,645
68,675
56,646
57,041
-
Operating income or loss
-81,621
-75,645
-68,675
-56,646
-57,041
-
Interest expense
4,330
3,333
262
-
-
-
Total other income/expenses net
-45
-28
-319
-189
247
-
Income before tax
-77,112
-71,169
-67,061
-56,624
-56,424
-
Income from continuing operations
-77,112
-71,169
-67,061
-56,624
-56,424
-
Net income
-77,112
-71,169
-67,061
-56,624
-56,424
-
Net income available to common shareholders
-77,112
-71,169
-67,061
-56,624
-56,424
-
Basic EPS
-1.44
-
-1.78
-1.78
-5.11
-1.30
Diluted EPS
-1.44
-
-1.78
-1.78
-5.11
-1.30
Basic average shares
47,317
-
37,763
23,558
11,037
15,159
Diluted average shares
47,317
-
37,763
23,558
11,037
15,159
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.